Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 1275 of 2228 entries
View as:

Active Surveillance Research Program for the Assessment of the Safety and the Effectiveness of Linagliptin

Phase: N/A Priority: Normal
NCT ID: NCT02197078 Org: User:
Start: 07/30/14 End: 02/26/19 Due: 02/26/20

Comparative Effectiveness of COPD Treatments

Phase: N/A Priority: Normal
NCT ID: NCT03376295 Org: User:
Start: 12/01/17 End: 12/31/17 Due: 12/31/18

Efficacy and Safety of Meloxicam (Mobicox®) in Mexican Population With Rheumatic Diseases

Phase: N/A Priority: Normal
NCT ID: NCT02184039 Org: User:
Start: 05/31/03 End: - Due: -

Clinical Study of BNS003 on Swelling in Legs Due to Venous Reflux

Phase: N/A Priority: Normal
NCT ID: NCT02211898 Org: User:
Start: 07/31/04 End: - Due: -

A Study to Test How Well Different Doses of BI 765250 Are Tolerated by People With a Skin Disease Called Plaque Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT05728489 Org: User:
Start: 04/27/23 End: 02/24/25 Due: 02/24/26

A Study to Test How Well Healthy People Tolerate Spesolimab When Given in 2 Different Ways

Phase: N/A Priority: Normal
NCT ID: NCT06520514 Org: User:
Start: 08/07/24 End: 01/15/25 Due: 01/15/26

Safety and Efficacy of Berodual® Respimat® Compared to Berodual® MDI (Metered Dose Inhaler) in Asthma Patients

Phase: N/A Priority: Normal
NCT ID: NCT02182479 Org: User:
Start: 04/30/98 End: - Due: -

Actuation Indicator Trial in Patients With COPD

Phase: N/A Priority: Normal
NCT ID: NCT00928746 Org: User:
Start: 06/30/09 End: - Due: -

WAL 801 CL Dry Syrup in Paediatric Atopic Dermatitis Patients

Phase: N/A Priority: Normal
NCT ID: NCT02182557 Org: User:
Start: 06/30/01 End: - Due: -

This Study Uses the SITS Registry to Find Out When Patients With a Heart Rhythm Disorder (Atrial Fibrillation) Start Treatment With Dabigatran After They Had a Stroke

Phase: N/A Priority: Normal
NCT ID: NCT03258645 Org: User:
Start: 11/15/18 End: 06/17/19 Due: 06/17/20

A Study to Test Different Doses of BI 1701963 Alone and Combined With Trametinib in Patients With Different Types of Advanced Cancer (Solid Tumours With KRAS Mutation)

Phase: N/A Priority: Normal
NCT ID: NCT04111458 Org: User:
Start: 11/04/19 End: 12/31/25 Due: 12/31/26

Study to Compare Prescription Non-Steroidal Anti-Inflammatory Drug (NSAID) Changes, Health Care Utilization, Efficacy and Safety of Meloxicam 7.5 mg Versus Usual Care Administration of Prescription NSAIDs in a Managed Healthcare Setting in Patients With Osteoarthritis

Phase: N/A Priority: Normal
NCT ID: NCT02183064 Org: User:
Start: 10/31/98 End: - Due: -

Nintedanib Plus Docetaxel in Japanese Patients With Adenocarcinoma Subtype Non-small Cell Lung Cancer After Failure of First Line Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT02300298 Org: User:
Start: 12/24/14 End: 10/27/17 Due: 10/27/18

EMPA-KIDNEY (The Study of Heart and Kidney Protection With Empagliflozin)

Phase: N/A Priority: Normal
NCT ID: NCT03594110 Org: User:
Start: 01/31/19 End: 07/02/24 Due: 07/02/25

Efficacy and Safety of Empagliflozin (BI 10773) in Type 2 Diabetes Patients on a Background of Pioglitazone Alone or With Metformin

Phase: N/A Priority: Normal
NCT ID: NCT01210001 Org: User:
Start: 09/30/10 End: - Due: -

Multiple Rising Oral Doses of BI 1060469 in Healthy Subjects and Mild Asthma Patients

Phase: N/A Priority: Normal
NCT ID: NCT02126865 Org: User:
Start: 05/31/14 End: 07/31/15 Due: 07/31/16

Postmarketing Surveillance Study of Atrovent® in Chronic Obstructive Airways Disease

Phase: N/A Priority: Normal
NCT ID: NCT02236715 Org: User:
Start: 09/30/99 End: - Due: -

Length of Stay in NVAF Patients Hospitalized and Initiated With Dabigatran or Warfarin in Japan

Phase: N/A Priority: Normal
NCT ID: NCT02631057 Org: User:
Start: 09/01/16 End: 09/07/16 Due: 09/07/17

Tipranavir Dose-response Study Using a Prototype Self-emulsifying Drug Delivery System (SEDDS) Formulation in Treatment-naive HIV-1 Infected Patients Report on the Post-study Option, a Treatment of Triple Therapy With Delavirdine, ZDV and 3TC Without Tipranavir

Phase: N/A Priority: Normal
NCT ID: NCT02249130 Org: User:
Start: 03/31/99 End: - Due: -

Combination of Telmisartan and Simvastatin in the Treatment of Hypertension and Hypercholesterolemia

Phase: N/A Priority: Normal
NCT ID: NCT00316095 Org: User:
Start: 04/30/06 End: 08/31/07 Due: 08/31/08

To Assess the Risk of Acute Pancreatitis in Patients With Type 2 Diabetes Mellitus Treated With Empagliflozin

Phase: N/A Priority: Normal
NCT ID: NCT05162014 Org: User:
Start: 12/20/21 End: 09/12/22 Due: 09/12/23

A Study to Test How Well Empagliflozin Works in Japanese People With Type 2 Diabetes Who Are Older Than 65 Years

Phase: N/A Priority: Normal
NCT ID: NCT04531462 Org: User:
Start: 10/05/20 End: 08/26/22 Due: 08/26/23

Effect of Treatment With BIIL 284 BS on Exercise Endurance in Patients With Chronic Obstructive Pulmonary Disease

Phase: N/A Priority: Normal
NCT ID: NCT02249247 Org: User:
Start: 04/30/01 End: - Due: -

A Randomized, Double-blind, Active (Pramipexole 0.5 mg Tid) and Placebo Controlled, Study of Pramipexole Given 0.5 mg and 0.75 mg Bid Over 12-week Treatment in Early Parkinson's Disease (PD) Patients

Phase: N/A Priority: Normal
NCT ID: NCT00402233 Org: User:
Start: 11/30/06 End: - Due: -

Co-administration of Olodaterol Respimat® and Tiotropium Handihaler®

Phase: N/A Priority: Normal
NCT ID: NCT01696058 Org: User:
Start: 09/30/12 End: 10/31/13 Due: 10/31/14